An international collaborative study has identified the E2F2 protein as a potential new therapeutic target to prevent ...

A new international study has found that a protein called E2F2 could play a key role in preventing fatty liver disease from ...

What is Fatty Liver? Fatty liver, medically known as hepatic steatosis, occurs when there is an abnormal accumulation of fat ...

A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic ...

Liver steatosis is more prevalent than liver fibrosis in people with HIV, with significant risk factors including age, hypertension, and diabetes. Liver fibrosis prevalence is low, with integrase ...

Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include metabolic dysfunction-associated steatohepatitis (MASH), ...

Chronic liver disease (CLD) is a growing global health challenge, accounting for millions of deaths each year. Its major contributors include metabolic dysfunction-associated steatohepatitis (MASH), ...

Background and Aim: Chronic viral infections such as human immunodeficiency virus and hepatitis C virus (HCV) may decrease tissue response to insulin, thereby causing insulin resistance. In addition, ...

When comparing the 2 forms of liver disease directly, patients with MASLD had a higher prevalence of kidney stones (2.8%) than those with MASH (1.7%). The researchers noted that the finding challenges ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data on Vanoglipel (DA-1241), a ...